FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,872 letters match. Newest first.

  1. Nutrition Strength Ltd.

    FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.

    High risk
  2. Veterinary Select Formula dba Allergic Pet

    FDA warns Allergic Pet over unapproved Nuroplex animal drugs marketed for seizures and epilepsy in dogs and cats.

    High risk
  3. Guangzhou Sinocon Food Co., Ltd

    FDA warns Guangzhou Sinocon Food over food-safety violations in ready-to-eat Oat Beta Glucan powder, including pathogen hazards and inaccurate test certificates.

    High risk
  4. Bhargava Phytolab Private Limited

    FDA warns Bhargava Phytolab over drug and API current good manufacturing practice (CGMP) violations, including inadequate testing and sterility controls.

    High risk
  5. Viatris, Inc.

    FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.

    High risk
  6. Sombra Cosmetics, Inc.

    FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.

    High risk
  7. Akron Formulations India Private Limited

    Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.

    High risk
  8. Brands International Corporation

    Brands International, a Canadian drug manufacturer, limited an FDA inspection and had manufacturing quality violations including mold contamination.

    High risk
  9. Rontis Hellas S.A.

    Rontis Hellas made Cronus HP PTA balloon catheters with an unproven EtO sterilization process and inadequate US adverse-event reporting procedures.

    High risk
  10. Prime Vitality, Inc. dba Prime Peptides

    FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.

    High risk
  11. Xcel Research LLC

    FDA warned Xcel Research for selling unapproved peptide drugs online with human-use claims.

    High risk
  12. Summit Research Peptides

    FDA warned Summit Research Peptides for selling unapproved semaglutide, retatrutide, cagrilintide, tirzepatide, and mazdutide with drug claims.

    High risk
  13. Micro Orgo Chem

    Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.

    High risk
  14. Becton, Dickinson, and Company/CareFusion 303, Inc.

    FDA warned Becton Dickinson/CareFusion over Pyxis medication dispensing systems with unresolved software defects, missed MDR reports and unreported recalls.

    High risk
  15. Mid America Pet Food LLC

    FDA warned Mid America Pet Food after Salmonella-linked recalls and found persistent contamination and animal-food safety-rule violations at its Texas plant.

    High risk
  16. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  17. Guangzhou Four E’s Scientific Co., Ltd.

    FDA warns Guangzhou Four E’s over CGMP failures for OTC drugs, including a sterile-labeled product with inadequate sterility assurance.

    High risk
  18. Purcell International

    Purcell International imported cinnamon apple sauce linked to lead contamination without adequate foreign supplier verification.

    High risk
  19. WANABANA USA LLC

    WanaBana USA LLC failed to verify foreign supplier safety for lead-contaminated apple cinnamon puree pouches.

    High risk
  20. Caribbean Produce Exchange, LLC

    Caribbean Produce Exchange lacked required foreign supplier verification records for imported WanaBana apple cinnamon puree linked to lead recall.

    High risk
  21. Knickerbocker 365 Inc.

    FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.

    High risk
  22. Applied Therapeutics, Inc.

    Applied Therapeutics, a trial sponsor, failed to let FDA access deleted electronic trial data and omitted dosing-error information from its drug application.

    High risk
  23. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk
  24. Zhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.

    FDA warns Zhejiang Uniquality over inadequate OTC drug component testing and quality oversight; import alert issued.

    High risk
  25. Calavo Growers, Inc.

    Calavo Growers' papayas are adulterated because contracted growers lacked accessible toilet facilities.

    High risk
  26. Mena Food Group, LLC

    FDA says Mena Food Group made ready-to-eat bakery products under insanitary conditions and without allergen or CGMP controls.

    High risk
  27. Catwalk Cosmetic Laboratories Pty Ltd.

    FDA warns South African over-the-counter drug maker Catwalk Cosmetic Laboratories of current good manufacturing practice violations and import alert.

    High risk
  28. Eurosirel S.P.A

    FDA warns Eurosirel over CGMP failures in topical drugs and pain patches, including missing glycerin identity testing.

    High risk
  29. Hangzhou Huiji Biotechnology Co., Ltd.

    FDA warned Hangzhou Huiji Biotechnology over CGMP failures in OTC hand sanitizers, including missing glycerin and ethanol safety tests.

    High risk
  30. Stew Leonard’s Holdings LLC

    Stew Leonard's Danbury, CT bakery cookies were misbranded: labels omitted peanut and egg allergens tied to a consumer death.

    High risk
  31. Tova Industries, LLC

    Tova Industries was cited for missing required heat-and-acidity process controls and filings for acidified pancake syrups, vanilla flavorings, and soy sauces.

    High risk
  32. Rise N’ Shine Farm, Inc.

    FDA warns Rise N’ Shine Farm after inspection found Salmonella Enteritidis and shell egg safety violations at its Georgia farm.

    High risk
  33. Maruhachi Muramatsu Inc., Danchi Factory

    FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

    High risk
  34. Adept Medical Ltd.

    Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.

    High risk
  35. Kyokuyo Global Seafoods Co. LTD.

    FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.

    High risk
  36. Barohup Inc.

    Barohup Inc. lacked foreign supplier verification for imported foods and kept importing enoki mushrooms after a Listeria finding.

    High risk
  37. Procesadora Vikingo C.A.

    FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.

    High risk
  38. Originitalia SRL

    FDA warns Originitalia SRL over manufacturing quality failures in OTC drugs, including untested active ingredient and missing release testing.

    High risk
  39. Unexo Lifesciences, Private Limited

    FDA warned Unexo Lifesciences over serious CGMP violations, including data integrity failures and torn batch records for U.S.-bound drugs.

    High risk
  40. Colgate-Palmolive/Tom's of Maine, Inc.

    FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.

    High risk
  41. Frontier Biologics, LLC

    FDA warned Frontier Biologics of Waco, Texas, that its amniotic fluid and membrane products are unapproved drugs and unlicensed biologics.

    High risk
  42. Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.

    FDA cited Tianjin Darentang Jingwanhong Pharmaceutical for limiting a drug inspection and manufacturing violations at its China plant.

    High risk
  43. Golden Shrimp Seafood Joint Stock Company

    Golden Shrimp Seafood's frozen yellowfin tuna had an inadequate seafood safety plan for controlling histamine.

    High risk
  44. Zhejiang Qimei Cosmetics Co., Ltd.

    Zhejiang Qimei Cosmetics drew an FDA warning for CGMP violations in sterile-labeled OTC isopropyl alcohol prep pads.

    High risk
  45. Multaler et Cie SAS

    FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.

    High risk
  46. Owens & Minor, Inc. dba American Contract Systems, Inc.

    FDA warned Owens & Minor unit American Contract Systems over device quality-system violations for sterile kits, including failed sterilization bags and incomplete design verification.

    High risk
  47. Rongcheng Jiayuan Food Co., Ltd

    FDA says Rongcheng Jiayuan's canned tuna is adulterated due to seafood HACCP and low-acid canned food violations.

    High risk
  48. Rolence Ent. Inc.

    FDA warns Rolence Ent. Inc. over quality system and MDR failures for its XR-01 Portable X-ray System.

    High risk
  49. Micro-X Ltd.

    FDA warns Australia's Micro-X over design, CAPA and complaint failures on Rover mobile x-ray systems, plus unreported field corrections.

    High risk
  50. Armstrong County Memorial Hospital

    FDA warns Armstrong County Memorial Hospital review board over missing procedures and inadequate meeting minutes for drug research.

    Medium